Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.68 |
| ▸ | LMNA | P02545 | 3/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 2/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.43 |
| ▸ | MGAM | O43451 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | SI | P14410 | 1/20 | 0.42 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30366354 | 0.87 | TSHR (0.50) | TSHRLMNAKDM4EALDH1A1KMT2A | |
| SCHEMBL10481290 | 0.86 | TSHR (0.81) | TSHRLMNAKDM4EALDH1A1KMT2A | |
| SCHEMBL25187 | 0.86 | TSHR (0.81) | TSHRLMNAKDM4EALDH1A1KMT2A | |
| SCHEMBL8187268 | 0.85 | TSHR (0.71) | TSHRLMNAKDM4EALDH1A1KMT2A | |
| SCHEMBL9736474 | 0.85 | TSHR (0.64) | TSHRLMNAKDM4EALDH1A1KMT2A | |
| SCHEMBL10481289 | 0.83 | TSHR (0.77) | TSHRLMNAKDM4EALDH1A1KMT2A | |
| SCHEMBL6821605 | 0.83 | TSHR (0.61) | TSHRLMNAKDM4EALDH1A1KMT2A | |
| SCHEMBL14100963 | 0.83 | TSHR (0.61) | TSHRLMNAKDM4EALDH1A1KMT2A | |
| SCHEMBL7945009 | 0.83 | TSHR (0.61) | TSHRLMNAKDM4EALDH1A1KMT2A | |
| SCHEMBL10587561 | 0.83 | TSHR (0.61) | TSHRLMNAKDM4EALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107876092-A | The high stability titanium catalyst of ester exchange carbonate synthesis benzene methyl and diphenyl carbonate | 华东理工大学 | 2018-04-06 | — | — | CN | claimed |
| CN-107417719-A | A kind of titanium chelate catalyst for being used for carbonate synthesis benzene methyl and diphenyl carbonate | 华东理工大学 | 2017-12-01 | — | — | CN | claimed |
| US-4431848-A | Preparation of resorcinol and substituted resorcinols by liquid-phase dehydrogenation of 1,3-cyclic diones derived by vapor-phase cyclization of delta-keto carboxylic acid esters | KOPPERS COMPANY, INC. (US) | 1984-02-14 | — | — | US | claimed |
| US-4399310-A | Preparation of 1,3-cyclic diones by vapor phase cyclization of delta-keto carboxylic acid esters utilizing carrier condensable under ambient conditions | KOPPERS COMPANY, INC. (US) | 1983-08-16 | — | — | US | claimed |
| EP-4041795-B1 | BLOCKED ISOCYANATE POLYURETHANE COMPOSITIONS USING A NEW BLOCKING AGENT, METHOD OF MANUFACTURE AND USES THEREOF | CROMOGENIA UNITS (ES) | 2025-10-01 | — | — | EP | disclosed |
| US-20240317706-A1 | COMPOUNDS THAT MEDIATE PROTEIN DEGRADATION AND METHODS OF USE THEREOF | MONTE ROSA THERAPEUTICS AG (CH) | 2024-09-26 | — | — | US | disclosed |
| EP-4056670-B1 | METHOD FOR FRACTIONATING A SHEA EXTRACT | BIOSYNTHIS SARL (FR) | 2024-08-21 | — | — | EP | disclosed |
| US-20240158719-A1 | METHOD FOR FRACTIONATING A SHEA EXTRACT | BIOSYNTHIS (FR) | 2024-05-16 | — | — | US | disclosed |
| US-20240140888-A1 | COMPOSITION COMPRISING AN ALKANE AND AN OXOESTER | BIOSYNTHIS (FR) | 2024-05-02 | — | — | US | disclosed |
| EP-4321651-A1 | COMPOSITION COMPRISING AN ALKANE AND AN OXO ESTER | Biosynthis (FR) | 2024-02-14 | — | — | EP | disclosed |
| EP-4305134-A1 | METHOD OF FRACTIONATING A SHEA EXTRACT | Biosynthis (FR) | 2024-01-17 | — | — | EP | disclosed |
| US-11655314-B2 | Photoinitiators for light-curable compositions | TECHNISCHE UNIVERSITAET WIEN (AT) | 2023-05-23 | — | — | US | disclosed |
| EP-0322245-A2 | Process for preparation of resorcinol | INDSPEC CHEMICAL CORPORATION (US) | 1989-06-28 | — | — | EP | disclosed |
| US-4837356-A | Process for the preparation of alkyl 4-ketoalkanoates | SHELL OIL COMPANY (US) | 1989-06-06 | — | — | US | disclosed |
| US-4837356-A | Process for the preparation of alkyl 4-ketoalkanoates | SHELL OIL COMPANY (US) | 1989-06-06 | — | — | US | disclosed |
| EP-0308956-A2 | Leukotriene LTD4 and LTB4 antagonists | G.D. Searle & Co. (US) | 1989-03-29 | — | — | EP | disclosed |
| EP-0279477-A1 | Carbonylation process | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1988-08-24 | — | — | EP | disclosed |
| EP-0166591-A2 | Indole-2-alkanoic acids and their use as prostaglandin antagonists | MERCK FROSST CANADA INC. (CA) | 1986-01-02 | — | — | EP | disclosed |
| US-4431848-A | Preparation of resorcinol and substituted resorcinols by liquid-phase dehydrogenation of 1,3-cyclic diones derived by vapor-phase cyclization of delta-keto carboxylic acid esters | KOPPERS COMPANY, INC. (US) | 1984-02-14 | — | — | US | disclosed |
| US-4399310-A | Preparation of 1,3-cyclic diones by vapor phase cyclization of delta-keto carboxylic acid esters utilizing carrier condensable under ambient conditions | KOPPERS COMPANY, INC. (US) | 1983-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240140888-A1 | COMPOSITION COMPRISING AN ALKANE AND AN OXOESTER | ALKBH2, ABHD12, FAAH2 | TSHR 3034/4885LMNA 876/4885KDM4E 2753/4885 |
| US-11655314-B2 | Photoinitiators for light-curable compositions | OXER1, PPOX, ORC3 | TSHR 2459/4885LMNA 1878/4885KDM4E 1856/4885 |
| US-20240317706-A1 | COMPOUNDS THAT MEDIATE PROTEIN DEGRADATION AND METHODS OF USE THEREOF | CDK2, SKP2, CDK1 | TSHR 3902/4885LMNA 2140/4885KDM4E 2198/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.